Ocular Therapeutix
OCUL
OCUL
69 hedge funds and large institutions have $86.4M invested in Ocular Therapeutix in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 73 → 69 (-4)
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
42% less capital invested
Capital invested by funds: $149M → $86.4M (-$62.6M)
Holders
69
Holding in Top 10
3
Calls
$565K
Puts
$416K
Top Buyers
| 1 | +$3.01M | |
| 2 | +$2.72M | |
| 3 | +$1.99M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$726K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$635K |
Top Sellers
| 1 | -$5.5M | |
| 2 | -$2.8M | |
| 3 | -$1.46M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.27M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.06M |